Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands.
Kwon D, Takata K, Zhang Z, Chong L, Fraser B, Zeisler J, Miyata-Takata T, Merkens H, Rousseau J, Aoki T, Kuo HT, Tan R, Zhang C, Lau J, Villa D, Uribe CF, Lin KS, Steidl C, Benard F.
Kwon D, et al. Among authors: tan r.
Clin Cancer Res. 2022 Apr 14;28(8):1628-1639. doi: 10.1158/1078-0432.CCR-21-3284.
Clin Cancer Res. 2022.
PMID: 35078860
Free PMC article.